Abstract:IntroductIon Schizophrenia is a devastating mental disorder affecting 20 million people worldwide. Early diagnosis is crucial for disease management and improvement in prognosis, and diagnostic biomarkers can serve as objective indicators for the early screening of the disease. Based on the observation of diminished flush responses to niacin in patients with schizophrenia, Horrobin proposed a noninvasive niacin skin flush screening for schizophrenia. Methods like optical reflection spectroscopy or laser Doppler flowmetry 8 are commonly used to evaluate niacin skin test results for diagnosis, but they heavily rely on medical instruments and thus, lack accessibility. Visual rating is a more accessible option, but it is subjective, easily affected by noise, and therefore less reliable. Adopting artificial intelligence (AI) technologies for image recognition, we developed a more dependable and accessible diagnostic system based on the niacin skin test that can be used for firstepisode schizophrenia (FES) screening. To implement our screening algorithm, we designed a portable device with data collection and processing features for FES screening that detects and evaluates the subject's degree of skinflushing response to niacin. Methods Our study included 54 patients with FES, 48 individuals at clinical high risk (CHR) for developing psychosis, and 73 healthy controls (HCs). The device we designed is shown in figure 1. The subject’s forearm is placed on the arm tray while holding the crossbar (figure 1A). Then, aqueous methylnicotinate is applied simultaneously in four dilutions (0.1 M, 0.01 M, 0.001 M, and 0.0001 M) to the inner forearm skin using filter paper patches. The patches are removed after 60 seconds. Five minutes after the removal, the camera above the tray takes four photographs of the arm at 5minute intervals with the fill lights turned on (figure 1B). This way, the photographs are collected from a fixed vertical view in a welllit environment, controlling data quality for the subsequent analysis. Generally, healthy people are more reactive to the niacin flush effects than patients with FES (figure 2A vs figure 2B). However, situations also occur where the reactions of healthy individuals and patients with FES are indistinguishable by visual judgement. Our diagnostic algorithm explained below overcomes this ambiguity by using statistical features to evaluate the ‘redness’ of the niacin flush response. We began by detecting the reaction areas using a convolutional neural network. Then, we quantified the images of the reaction areas (figure 3A,B) through the YCbCr colour system (figure 3C): Y, Cb, and Cr indicate the brightness, bluedifference, and reddifference chrominance components of each image, respectively. By encoding the ‘redness’ with the Cr parameter, we marked the area containing the erythema using the Cr values (figure 3D,E). We then collected the Cr values of individuals’ erythema, standardised by doi:10.1136/gpsych-2022-100753 Highlights

Comparison of Niacin Skin Flush Response in Patients with Schizophrenia and Bipolar Disorder

Identification of Adolescent Patients with Depression Via Assessment of the Niacin Skin Flushing Response.

Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker

Niacin sensitivity and cognitive functions in first episode schizophrenia

Attenuated niacin-induced skin flush response in individuals with clinical high risk for psychosis

Diagnostic Value of Niacin Skin Blunting Response in Adolescent Patients with Depression

Artificial Intelligence-Assisted Niacin Skin Flush Screening in Early Psychosis Identification and Prediction

Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population.

Membrane fatty acids, niacin flushing and clinical parameters

Study of niacin skin flushing response for the diagnosis of major depressive disorder.

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis

[Test for abnormal niacin response syndrome in schizophrenia: reclaiming the oral route]

Correlation between niacin skin flushing and cognitive function in patients with depression

Attenuated Niacin Skin Flushing Response in Children and Adolescents with Mental Disorders: A Transdiagnostic Early Warning Marker

Potential of niacin skin flush response in adolescent depression identification and severity assessment: a case-control study

A potential objective marker in first-episode schizophrenia based on abnormal niacin response

Replication of the Abnormal Niacin Response in First Episode Psychosis Measured Using Laser Doppler Flowmeter

Association of Attenuated Niacin Response with Inflammatory Imbalance and Prediction of Conversion to Psychosis from Clinical High-risk Stage

Causal associations between niacin bluntness and schizophrenia: a GWAS and Mendelian randomization study

An Investigation of Calcium-Independent Phospholipase A2 (ipla2) and Cytosolic Phospholipase A2 (cpla2) in Schizophrenia

Attenuated Niacin Response is Associated with a Subtype of First-Episode Drug-Naïve Psychosis Characterized As Serious Negative Symptoms